278 related articles for article (PubMed ID: 28606091)
1. LASP2 suppresses colorectal cancer progression through JNK/p38 MAPK pathway meditated epithelial-mesenchymal transition.
Wang B; Zhang L; Zhao L; Zhou R; Ding Y; Li G; Zhao L
Cell Commun Signal; 2017 Jun; 15(1):21. PubMed ID: 28606091
[TBL] [Abstract][Full Text] [Related]
2. Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients.
Zhang X; Cai L; Zhou H; Liu Y; Fan C; Wang L; Li A; Miao Y; Li Q; Qiu X; Wang E
Mol Carcinog; 2017 Dec; 56(12):2558-2565. PubMed ID: 28667800
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of LASP2 inhibits pancreatic cancer cell migration and invasion through suppressing TGF-β-induced EMT.
Zhang Y; Li JH; Yuan QG; Cao G; Yang WB
J Cell Biochem; 2019 Aug; 120(8):13651-13657. PubMed ID: 30945341
[TBL] [Abstract][Full Text] [Related]
4. LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression.
Wang H; Shi J; Luo Y; Liao Q; Niu Y; Zhang F; Shao Z; Ding Y; Zhao L
Clin Cancer Res; 2014 Nov; 20(22):5835-47. PubMed ID: 25252758
[TBL] [Abstract][Full Text] [Related]
5. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
[TBL] [Abstract][Full Text] [Related]
6. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
[TBL] [Abstract][Full Text] [Related]
7. S100A16 suppresses the proliferation, migration and invasion of colorectal cancer cells in part via the JNK/p38 MAPK pathway.
Ou S; Liao Y; Shi J; Tang J; Ye Y; Wu F; Wang W; Fei J; Xie F; Bai L
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355370
[TBL] [Abstract][Full Text] [Related]
8. [Expression of LIM and SH3 protein 1 in renal clear cell carcinoma and its effects on invasion and migration of renal clear cell carcinoma 786-O cells].
Jin B; Gao L; Li W; Chen JC; Wen RM; Wang JQ
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):166-171. PubMed ID: 28316213
[No Abstract] [Full Text] [Related]
9. Knockdown on aPKC-ι inhibits epithelial-mesenchymal transition, migration and invasion of colorectal cancer cells through Rac1-JNK pathway.
Du GS; Qiu Y; Wang WS; Peng K; Zhang ZC; Li XS; Xiao WD; Yang H
Exp Mol Pathol; 2019 Apr; 107():57-67. PubMed ID: 30465755
[TBL] [Abstract][Full Text] [Related]
10. CSRP2 suppresses colorectal cancer progression
Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of LASP2 inhibits the proliferation, migration, and invasion of cervical cancer cells.
Zhang Y; Zhang L
J Cell Biochem; 2019 Sep; 120(9):15389-15396. PubMed ID: 31026088
[TBL] [Abstract][Full Text] [Related]
12. LASP1-S100A11 axis promotes colorectal cancer aggressiveness by modulating TGFβ/Smad signaling.
Niu Y; Shao Z; Wang H; Yang J; Zhang F; Luo Y; Xu L; Ding Y; Zhao L
Sci Rep; 2016 May; 6():26112. PubMed ID: 27181092
[TBL] [Abstract][Full Text] [Related]
13. Loss of the 14-3-3σ is essential for LASP1-mediated colorectal cancer progression via activating PI3K/AKT signaling pathway.
Shao Z; Cai Y; Xu L; Yao X; Shi J; Zhang F; Luo Y; Zheng K; Liu J; Deng F; Li R; Zhang L; Wang H; Li M; Ding Y; Zhao L
Sci Rep; 2016 May; 6():25631. PubMed ID: 27156963
[TBL] [Abstract][Full Text] [Related]
14. TES inhibits colorectal cancer progression through activation of p38.
Li H; Huang K; Gao L; Wang L; Niu Y; Liu H; Wang Z; Wang L; Wang G; Wang J
Oncotarget; 2016 Jul; 7(29):45819-45836. PubMed ID: 27323777
[TBL] [Abstract][Full Text] [Related]
15. LASP2 functions as a potential prognostic factor and therapeutic target in nasopharyngeal carcinoma.
Yang YT; Nie LM; Wei QF; Li WZ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9416-9422. PubMed ID: 33015783
[TBL] [Abstract][Full Text] [Related]
16. LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition.
Zhong C; Li X; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
Biomed Pharmacother; 2019 Aug; 116():109013. PubMed ID: 31146105
[TBL] [Abstract][Full Text] [Related]
17. BMAL1 promotes colorectal cancer cell migration and invasion through ERK- and JNK-dependent c-Myc expression.
Shan L; Zheng W; Bai B; Hu J; Lv Y; Chen K; Wang X; Pan Y; Huang X; Zhu H; Dai S
Cancer Med; 2023 Feb; 12(4):4472-4485. PubMed ID: 36806631
[TBL] [Abstract][Full Text] [Related]
18. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
[TBL] [Abstract][Full Text] [Related]
19. miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.
Chen J; Zhang H; Chen Y; Qiao G; Jiang W; Ni P; Liu X; Ma L
Exp Cell Res; 2017 Mar; 352(1):104-112. PubMed ID: 28161537
[TBL] [Abstract][Full Text] [Related]
20. [Role of allograft inflammatory factor-1 in regulating the proliferation, migration and apoptosis of colorectal cancer cells].
Ai XL; Yao F; Wang XJ; Duan DB; Li K; Hu ZY; Yin G; Wang M; Wu BY
Nan Fang Yi Ke Da Xue Xue Bao; 2018 May; 38(5):511-519. PubMed ID: 29891445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]